Medartis Holding AGXSWX:MED +2.16%84 3-Year ROIIC % is 1.44 as of Dec. 2025, which is 1957% above its 10-year median of 0.07. GuruFocus rates XSWX:MED with a GF Score™ of 84/100 and a GF Value™ of CHF106.42 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 799 Medical Devices & Instruments companies, Medartis Holding AG ranks worse than 50.44% on this metric.
3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
Medartis Holding AG's 3-Year ROIIC % for the quarter that ended in Dec. 2025 was 1.44%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for Medartis Holding AG's 3-Year ROIIC % or its related term are showing as below:
XSWX:MED's 3-Year ROIIC % is ranked worse than 50.44% of 799
companies
in the Medical Devices & Instruments industry
Industry Median: 1.78
vs XSWX:MED: 1.44
Medartis Holding AG (XSWX:MED) 3-Year ROIIC % Explanation
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Medartis Holding AG 3-Year ROIIC % Related Terms
Medartis Holding AG 3-Year ROIIC % Historical Data
* Premium members only.
The historical data trend for Medartis Holding AG's 3-Year ROIIC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XSWX:MED vs ABT, SYK, MDT: 3-Year ROIIC % Comparison
For the Medical Devices subindustry, Medartis Holding AG's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medartis Holding AG 3-Year ROIIC % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Medartis Holding AG's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Medartis Holding AG's 3-Year ROIIC % falls into.
Medartis Holding AG's 3-Year ROIIC % for the quarter that ended in Dec. 2025 is calculated as:
3-Year ROIIC %
=
3-Year Incremental Net Operating Profit After Taxes (NOPAT)**
/
3-Year Incremental Invested Capital**
=
( 1.41182 (Dec. 2025) - -1.513578 (Dec. 2022) )
/
( 491.097 (Dec. 2025) - 287.413 (Dec. 2022) )
=
2.925398
/
203.684
=
1.44%***
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Medartis Holding AG (XSWX:MED) has a 3-Year ROIIC % of 1.44 as of Dec. 2025. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Medartis Holding AG and its competitors. This is 1957% above median its historical median of 0.07. According to the industry distribution chart, Medartis Holding AG ranks #403 out of 799 companies in the Medical Devices & Instruments industry, placing it in the top 50.4%.
Is Medartis Holding AG's 3-Year ROIIC % too high?
Medartis Holding AG's current 3-Year ROIIC % of 1.44 is 1957% above median its 10-year median of 0.07. The Medical Devices & Instruments industry median 3-Year ROIIC % is 1.78. Medartis Holding AG's value of 1.44 is 19.1% below this industry median. Based on the distribution chart, Medartis Holding AG ranks #403 out of 799 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Medartis Holding AG has a GF Score™ of 84/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Medartis Holding AG's 3-Year ROIIC % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Medartis Holding AG ranks #403 out of 799 companies for 3-Year ROIIC %. This places Medartis Holding AG in the lower half of its industry. The industry median 3-Year ROIIC % is 1.78. Medartis Holding AG's value of 1.44 is 19.1% below this benchmark. While the company's 10-year median is 0.07 vs. the industry median of 1.78, Medartis Holding AG has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Medical Devices & Instruments company?
The median 3-Year ROIIC % among Medical Devices & Instruments companies is 1.78, based on 799 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medartis Holding AG's current 3-Year ROIIC % of 1.44 is 19.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Medartis Holding AG and its competitors. For the Medical Devices & Instruments industry, the median 3-Year ROIIC % is 1.78 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medartis Holding AG's current 3-Year ROIIC % is 1.44, which is 1957% above median its own 10-year median of 0.07. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medartis Holding AG stock overvalued right now?
Based on GuruFocus' analysis, Medartis Holding AG (XSWX:MED) is currently considered Modestly Undervalued. The stock's GF Value™ is CHF106.42, compared to a current price of CHF85.30 — trading 19.8% below its estimated fair value. The current 3-Year ROIIC % is 1.44, which is 1957% above median its 10-year median of 0.07 and 19.1% below the Medical Devices & Instruments industry median of 1.78. Medartis Holding AG's overall GF Score™ is 84/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For Medartis Holding AG (XSWX:MED), the current 3-Year ROIIC % is 1.44 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medartis Holding AG (XSWX:MED) Overvalued in 2026?
Based on GuruFocus' analysis, Medartis Holding AG stock appears to be undervalued.
The current stock price of CHF85.30 is trading 19.8% below its estimated GF Value™ of CHF106.42.
GuruFocus considers Medartis Holding AG to be Modestly Undervalued.
Key valuation signals for XSWX:MED:
3-Year ROIIC %: 1.44 (1957% above median its 10-year median of 0.07)
GF Value™: CHF106.42 vs. price of CHF85.30 (19.8% below fair value)
Industry Position: 19.1% below the Medical Devices & Instruments median (#403 of 799)
No single metric tells the full story. See the XSWX:MED stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medartis Holding AG is a medical device company. The company's product profile is divided into APTUS products, StealthFix Products, and MODUS products. APTUS includes products for the Hand, Wrist, Elbow, Shoulder, and Foot. MODUS comprises products for the mandible. Geographically, it derives the majority of its revenue from Europe, Middle East and Africa (EMEA) and also has a presence in North America, Asia Pacific, and Latin America.
84GF Score
Get the complete analysis for XSWX:MED
3-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:MED has been successfully added to your 
